Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective ...

differentiation of iPS cells into relevant cell types in vitro for transplantation, and removal of contaminating stem or progenitor cells before transplantation. Study of abnormal phenotypes ...

iPSC-based therapies could replace ... raising the hope that new cells can be encouraged to grow from intrinsic progenitor cells. Nevertheless, despite more than a decade of studies, it has ...

Induced neural progenitor cells (iNPCs), derived from induced pluripotent stem cells (iPSCs), are a relatively new method for modeling the cellular interactivity, biochemical alterations, and ...

Organoids are made to model human organs and are promising for research and therapy, but there are limitations in their ...

A recent study found that placenta-derived IL1α under hypoxic conditions, can greatly increase growth of human stem ...

Use Applied StemCell's (ASC) new GMP facility, comprised of five cleanrooms equipped with cutting-edge technology, to develop the next generation of iPSC-derived therapeutics. We have dedicated ...

In hopes of identifying this subset of we have undertaken an extensive transcriptome analysis of paired trisomic/disomic induced pluripotent stem cells (iPSCs) and cortical neuronal cultures derived ...